Sumitomo Chemical India Ltd

Sumitomo Chemical India Ltd

₹ 419 2.26%
29 Mar - close price
About

Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With the integration of Excel Crop Care Limited, the Company now has a strong portfolio of generics in addition to specialty products and a strong combined marketing network. With this integration, the Company has moved up several notches in the pecking order of the Indian crop protection industry. SCIL has also marked its presence in Africa and several other geographies of the world.[1] [2]

Key Points

Products
The Company has a presence in all the product segments - insecticides, weedicides, fungicides, fumigants and rodenticides, plant growth nutrition products, bio-rationals, and plant growth regulators. The Company is known for domestic marketing of proprietary products of its Japanese parent – Sumitomo Chemical Company, Limited in agrochemicals, animal nutrition, and environmental health business segments. [1]

The products comprise conventional chemistry sourced from the parent company, SCC, and biological products sourced from a USA-based subsidiary, Valent Biosciences LLC, a leader in producing a range of naturally occurring, environmentally compatible pesticides and plant growth regulators, for over 40 years. [2]

  • Market Cap 20,934 Cr.
  • Current Price 419
  • High / Low 541 / 395
  • Stock P/E 41.4
  • Book Value 44.4
  • Dividend Yield 0.24 %
  • ROCE 33.7 %
  • ROE 25.1 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 47.7% CAGR over last 5 years

Cons

  • Stock is trading at 9.44 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
525 445 646 903 560 534 782 910 707 665 986 1,122 754
478 403 528 683 482 463 631 695 580 556 798 843 633
Operating Profit 46 41 118 220 78 71 150 215 127 109 188 278 121
OPM % 9% 9% 18% 24% 14% 13% 19% 24% 18% 16% 19% 25% 16%
-24 4 2 6 6 5 5 8 15 7 5 11 13
Interest 1 1 1 2 1 1 2 2 2 1 1 1 1
Depreciation 10 13 11 11 11 13 11 11 11 11 11 15 11
Profit before tax 11 31 108 213 71 61 143 210 129 104 180 272 121
Tax % 91% 27% 27% 26% 24% 12% 26% 26% 24% 28% 23% 26% 25%
Net Profit 1 23 79 158 54 54 106 155 98 75 138 202 91
EPS in Rs 0.02 0.46 1.57 3.17 1.09 1.09 2.13 3.11 1.96 1.50 2.77 4.05 1.82
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
229 451 495 635 671 724 799 1,911 2,223 2,423 2,643 3,064 3,526
250 463 484 587 614 635 698 1,691 1,932 2,088 2,155 2,461 2,830
Operating Profit -21 -12 10 48 57 89 101 219 291 335 488 603 696
OPM % -9% -3% 2% 8% 8% 12% 13% 11% 13% 14% 18% 20% 20%
1 1 3 3 8 26 10 31 -0 -20 19 36 36
Interest 0 0 0 2 1 1 1 5 5 7 7 8 5
Depreciation 0 0 0 6 6 7 7 24 28 41 47 45 49
Profit before tax -20 -11 13 43 58 107 103 221 258 267 453 586 678
Tax % 0% 0% 0% 23% 40% 40% 40% 34% 35% 23% 24% 26%
Net Profit -20 -11 13 33 35 65 62 145 167 206 345 434 506
EPS in Rs 4.12 6.92 8.69 10.14
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 38% 18% 12% 12%
Compounded Sales Growth
10 Years: 21%
5 Years: 31%
3 Years: 11%
TTM: 20%
Compounded Profit Growth
10 Years: 46%
5 Years: 48%
3 Years: 36%
TTM: 22%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 36%
1 Year: -1%
Return on Equity
10 Years: 21%
5 Years: 22%
3 Years: 24%
Last Year: 25%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
136 233 233 233 233 233 275 275 275 499 499 499 499
Reserves -72 -82 -70 -36 -2 63 360 665 761 710 1,029 1,425 1,718
52 0 1 0 0 0 0 10 20 36 33 38 32
68 208 202 243 234 280 288 695 791 848 1,097 1,047 1,206
Total Liabilities 185 359 367 440 466 576 922 1,644 1,846 2,093 2,658 3,009 3,455
10 53 48 47 51 52 53 267 279 319 309 390 431
CWIP 0 0 0 0 0 1 7 9 8 10 14 35 23
Investments 0 0 0 0 0 0 277 2 1 87 291 357 312
175 306 319 393 415 523 585 1,367 1,558 1,676 2,043 2,227 2,689
Total Assets 185 359 367 440 466 576 922 1,644 1,846 2,093 2,658 3,009 3,455

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
-8 75 -16 20 4 52 -21 49 75 222 424 223
-0 -2 -1 -8 -8 -5 -289 -40 -35 -118 -282 -281
8 -49 0 -1 0 -0 276 7 -65 -61 -47 -63
Net Cash Flow 0 24 -17 11 -4 47 -34 16 -26 43 95 -120

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 138 105 96 90 83 92 101 105 110 128 117 100
Inventory Days 125 135 169 191 202 193 133 185 198
Days Payable 134 109 132 115 176 136 112 145 110
Cash Conversion Cycle 138 105 96 81 109 130 177 131 167 150 157 189
Working Capital Days 156 42 62 58 69 79 113 115 119 111 97 128
ROCE % -8% 8% 25% 27% 41% 22% 29% 27% 26% 33% 34%

Shareholding Pattern

Numbers in percentages

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
80.30 78.30 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00
0.05 0.76 0.77 1.15 1.12 1.22 1.32 1.36 1.69 1.90 2.05 2.44
4.60 4.96 5.27 6.61 6.29 6.57 6.13 6.17 6.36 6.70 6.39 5.52
15.05 15.98 18.96 17.24 17.59 17.21 17.55 17.47 16.95 16.40 16.54 17.02

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents